EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Pharmacodynamic Model of the Hemodynamic Effects of Propofol and Remifentanil and Their Interaction with Noxious Stimulation

Maite Garraza-Obaldia iD, Sebastian Jaramillo iD, Zinnia P Parra-Guillen iD, José F Valencia iD, Pedro L Gambús iD, Iñaki F Trocóniz iD

Pharmaceutics · 19.12.2024 · 16 (12) · 1615

DOI: 10.3390/pharmaceutics16121615 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pharmaceutics, online erschienen am 19.12.2024. Verfasst von Maite Garraza-Obaldia und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutical Sciences, School of Pharmacy and Nutrition, University of Navarra, 31008 Pamplona, Spain. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: “Asociación de Amigos de la Universidad de Navarra” fellowship, “la Caixa” Banking Foundation, MINCIENCIAS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Despite the known impact of propofol and remifentanil on hemodynamics and patient outcomes, there is a lack of comprehensive quantitative analysis, particularly in surgical settings, considering the influence of noxious stimuli. The aim of this study was to develop a quantitative semi-mechanistic population model that characterized the time course changes in mean arterial pressure (MAP) and heart rate (HR) due to the effects of propofol, remifentanil, and different types of noxious stimulation related to the clinical routine.

Methods

Data from a prospective study were used; the study analyzed the effects of propofol and remifentanil general anesthesia on female patients in physical status of I-II according to the American Society of Anesthesiologists (ASA I-II) undergoing gynecology surgery. Patients were consecutively assigned to different administration schemes of propofol and remifentanil targeted at different effect-site concentrations. Esophageal instrumentation, laryngeal mask airway insertion, hysteroscopy, and tetanus stimuli were applied. Data from patients with chronic hypertension were discarded.

Results

MAP and HR observations from 77 patients were analyzed. The hemodynamic effects were described using turn-over models incorporating feedback mechanisms. Analyses revealed that propofol and remifentanil elicited effects on the turn-over of MAP and HR, respectively, with estimates of plasma drug concentrations causing an inhibition-half of the maximum effect (C50) of 8.79 µg∙mL−1 and 4.57 ng∙mL−1. Hysteroscopy exerted an increase in MAP (but not in HR), which was well-characterized by the model, with a predicted typical increase of 28 mmHg and a dissipation half-life of 33 min. The impact of other noxious stimuli on MAP or HR could not be identified. Model simulations indicated that propofol and remifentanil, titrated to inhibit the motor response to noxious stimuli, regardless of dose combinations, cause a significant risk of hypotension, especially following induction and at the end of surgery (when surgical intervention is completed, before the awakening phase).

Conclusions

The developed semi-mechanistic and fully identifiable model provides quantitative information on how propofol, remifentanil, and surgical stimulus (hysteroscopy) interact to produce the hemodynamic changes (of MAP and HR) commonly observed in clinical practice.

Schlagwörter

Stichwörter der Autor:innen

PKPD modellinganesthesiaclinical routineheart ratehysteroscopymean arterial pressurepopulation approach

Autor:innen und Institutionen

  • Department of Pharmaceutical Sciences, School of Pharmacy and Nutrition, University of Navarra, 31008 Pamplona, Spain.
  • Navarra Institute for Health Research (IdiSNA), 31008 Pamplona, Spain.
  • Anesthesiology Department, Hospital CLINIC de Barcelona, 08036 Barcelona, Spain.
  • Biomedical Engineering Program, Universidad de San Buenaventura, Cali 111321, Colombia.
  • Institut d'Investigacions Biomèdiques Agusti Pi i Sunyer (IDIBAPS), 08036 Barcelona, Spain.
  • Institute of Data Science and Artificial Intelligence (DATAI), University of Navarra, 31008 Pamplona, Spain.

ORCID-Profile: Maite Garraza-Obaldia, Sebastian Jaramillo, Zinnia P Parra-Guillen, José F Valencia, Pedro L Gambús, Iñaki F Trocóniz

Förderung

  • “Asociación de Amigos de la Universidad de Navarra” fellowship
  • “la Caixa” Banking Foundation
  • MINCIENCIAS

Zitieren

APA

Garraza-Obaldia, M., Jaramillo, S., Parra-Guillen, Z. P., Valencia, J. F., Gambús, P. L., & Trocóniz, I. F. (2024). Pharmacodynamic Model of the Hemodynamic Effects of Propofol and Remifentanil and Their Interaction with Noxious Stimulation. Pharmaceutics, 16(12), 1615. https://doi.org/10.3390/pharmaceutics16121615

Vancouver

Garraza-Obaldia M, Jaramillo S, Parra-Guillen ZP, Valencia JF, Gambús PL, Trocóniz IF. Pharmacodynamic Model of the Hemodynamic Effects of Propofol and Remifentanil and Their Interaction with Noxious Stimulation. Pharmaceutics. 2024;16(12):1615. doi:10.3390/pharmaceutics16121615

BibTeX
@article{GarrazaObaldia2024,
  author = {Garraza-Obaldia, Maite and Jaramillo, Sebastian and Parra-Guillen, Zinnia P and Valencia, José F and Gambús, Pedro L and Trocóniz, Iñaki F},
  title = {Pharmacodynamic Model of the Hemodynamic Effects of Propofol and Remifentanil and Their Interaction with Noxious Stimulation},
  journal = {Pharmaceutics},
  year = {2024},
  volume = {16},
  number = {12},
  pages = {1615},
  doi = {10.3390/pharmaceutics16121615}
}
Kostenlos starten →